Zeev's Turnips Patch-No Politics (ZEEV)

[jeffsaxx]

good point regarding ELN --- and I think many fund managers are in fact awaiting the FDA approval and particularly the content of the labelling of tysabri before making any commitment to reinvest or add to any ELN holdings --- that should be due within a week --- but I'm not involved with ELN calls at this moment for that reason --- even though I do believe long term that once tysabri returns to market the MS population will demand the drug and it will rapidly capture dominance in the MS market--- sorry for what may appear too harsh a comment from me about VPHM --- I always wish good luck to all --- and I think from now on I'll keep my critical comments to myself particularly where I have no position in the subject company